Back
Enlivex Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
37
ENLV
Enlivex Therapeutics
Last Price:
1.19
Seasonality Move:
14.26%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight selling pressure.
Enlivex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Sell |
| 20-day SMA: | 1.14 | Buy |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.71 | Sell |
| 8-day EMA: | 1.2 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 1.62 | Sell |
Enlivex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.74 | Sell |
| Chaikin Money Flow: | -19201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.26) | Buy |
| Bollinger Bands (100): | (1.15 - 1.49) | Sell |
Enlivex Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enlivex Therapeutics Stock
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.18 while ENLV 8-day simple moving average is 1.22, which is a Sell signal.
- The stock price of ENLV is 1.18 while Enlivex Therapeutics 20-day SMA is 1.14, which makes it a Buy.
- Enlivex Therapeutics 50-day simple moving average is 1.28 while ENLV share price is 1.18, making it a Sell technically.
- ENLV stock price is 1.18 and Enlivex Therapeutics 200-day simple moving average is 1.71, creating a Sell signal.
ENLV Technical Analysis vs Fundamental Analysis
Sell
37
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy or a Sell?
-
Enlivex Therapeutics stock is rated a Sell
The current Enlivex Therapeutics [ENLV] share price is $1.18. The Score for ENLV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Enlivex Therapeutics Stock Info
Market Cap:
25.95M
Price in USD:
1.18
Share Volume:
211.21K
Enlivex Therapeutics 52-Week Range
52-Week High:
4.59
52-Week Low:
0.81
Sell
37
Enlivex Therapeutics (ENLV)
is a Sell
Enlivex Therapeutics Share Price Forecast
-
What is the Enlivex Therapeutics stock price today?
The Enlivex Therapeutics stock price is 1.18 USD today. -
Will ENLV stock go up or go down?
Enlivex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enlivex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enlivex Therapeutics is overvalued.
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.18 while ENLV 8-day exponential moving average is 1.20, which is a Sell signal.
- The stock price of ENLV is 1.18 while Enlivex Therapeutics 20-day EMA is 1.20, which makes it a Sell.
- Enlivex Therapeutics 50-day exponential moving average is 1.25 while ENLV share price is 1.18, making it a Sell technically.
- ENLV stock price is 1.18 and Enlivex Therapeutics 200-day simple moving average is 1.62, creating a Sell signal.
Fundamental Analysis of Enlivex Therapeutics
Is Enlivex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.07 per share.
Technical Analysis of Enlivex Therapeutics
Should I short Enlivex Therapeutics stock?
- ENLV Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Enlivex Therapeutics is a Sell
- Enlivex Therapeutics Relative Strength Index (RSI) is 47.74, which suggest Enlivex Therapeutics is oversold
- The Bollinger Bands (25) for Enlivex Therapeutics is (1.02 - 1.26), which suggest Enlivex Therapeutics is a Sell
- The Bollinger Bands (100) for Enlivex Therapeutics is (1.15 - 1.49), which suggest Enlivex Therapeutics is a Sell
* Enlivex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.